【レポートの概要（一部）】
1. Report Overview
1.1 The Drug Discovery Outsourcing Market Overview
1.2 Drug Discovery Outsourcing Market Segmentation
1.3 Why You Should Read This Report
1.4 How This Report Delivers
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report For?
1.7 Methodology
1.8 Frequently Asked Questions (FAQ)
1.9 Associated Reports
2. An Introduction to Drug Discovery Outsourcing
2.1 What is Outsourcing?
2.2 What is Drug Discovery Outsourcing?
2.3 Why Outsource Drug Discovery?
2.4 A Common Drug Discovery Model Includes Pharma Collaborations with Academia
2.5 The Outsource Model for Drug Development Increases Innovation
2.6 Outsourced Processes in Drug Discovery
2.7 Challenges with Drug Discovery Outsourcing
2.8 Emerging Markets are a Popular Destination for CROs
2.9 Strategic Partnerships to Acquisitions
2.10 Recent Drug Development Outsourcing Agreements
2.11 Glossary of Terms Related to Drug Discovery Outsourcing
3. Global Drug Discovery Outsourcing Market and Service Area Submarkets, 2015-2025
3.1 Drug Discovery Outsourcing: Global Market Overview
3.2 The Global Drug Discovery Outsourcing Market Sectors
3.3 The Global Drug Discovery Outsourcing Market by Sector, 2014
3.4 The Global Drug Discovery Outsourcing Market by Sector, 2015-2025
3.5 The Changing Market Shares by Sector, 2015-2025
3.6 The Global Chemistry Services Outsourcing Market, 2014
3.6.1 Libraries
3.6.2 Building Blocks
3.6.3 Compound Synthesis
3.6.4 The Global Chemistry Services Outsourcing Market Forecast, 2015-2025
3.7 The Global Biology Services Outsourcing Market, 2014
3.7.1 Target Identification
3.7.2 Target Validation
3.7.3 The Global Biology Services Outsourcing Market Forecast, 2015-2025
3.8 The Global Lead Optimisation Market, 2014
3.8.1 ADMET Screening: Prevents Late Stage Failure of Clinical Trials
3.8.2 The Global Lead Optimisation Market Forecast, 2015-2025
3.9 The Global Lead Identification and Screening Outsourcing Market, 2014
3.9.1 Methods of Screening in Drug Discovery
3.9.2 Primary Screening
3.9.3 The Global Lead Identification and Screening Outsourcing Market Forecast, 2015-2025
4. The Leading National Markets in the Drug Discovery Outsourcing Markets 2015-2025
4.1 Drug Discovery Outsourcing Overview
4.2 The Leading National Markets in the Drug Discovery Outsourcing Market, 2014
4.3 The Leading National Markets in the Drug Discovery Outsourcing Market, 2015-2025
4.4 The Changing Market Shares of the Leading National Markets in the Drug Discovery
Outsourcing Market, 2015-2025
4.5 CAGRS of the Leading National Markets in the Drug Discovery Outsourcing Market, 2015-2025
4.6 The US Drug Discovery Outsourcing Market Sales Forecast, 2015-2025
4.7 The EU5 Drug Discovery Outsourcing Market by Region, 2014
4.7.1 The EU5 Drug Discovery Outsourcing Market Forecast, 2015-2025
4.7.2 CAGRS by EU5 Region, 2015-2025
4.7.3 The EU5 Changing Market Shares by Country 2015-2025
4.7.3.1 The German Drug Discovery Outsourcing Market Sales Forecast, 2015-2025
4.7.3.2 The UK Drug Discovery Outsourcing Market Sales Forecast, 2015-2025
4.7.3.3 The French Drug Discovery Outsourcing Market Sales Forecast, 2015-2025
4.7.3.4 The Italian Drug Discovery Outsourcing Market Sales Forecast, 2015-2025
4.7.3.5 The Spanish Drug Discovery Outsourcing Market Sales Forecast, 2015-2025
4.8 The Japanese Drug Discovery Outsourcing Market Sales Forecast, 2015-2025
4.9 The Chinese Drug Discovery Outsourcing Market Sales Forecast, 2015-2025
4.9.1 Challenges to China’s Growth
4.10 The Indian Drug Discovery Outsourcing Market Sales Forecast, 2015-2025
4.11 The Brazilian Drug Discovery Outsourcing Market Sales Forecast, 2015-2025
4.12 The Russian Drug Discovery Outsourcing Market Sales Forecast, 2015-2025
4.13 The South Korean Drug Discovery Outsourcing Market Sales Forecast, 2015-2025
4.14 The Mexican Drug Discovery Outsourcing Market Sales Forecast, 2015-2025
4.15 The Rest of the World Drug Discovery Outsourcing Market Sales Forecast, 2015-2025
5. Leading Companies in the Drug Discovery Outsourcing Market in 2015
5.1 Drug Discovery Outsourcing: A Fragmented and Growing Marketplace
5.2 Characteristics of Leading Contract Research Organisations
5.2.1 A Highly Quality Workforce
5.2.2 Emphasis on Intellectual Property Protection
5.2.3 Long Term Working Relationship
5.2.4 Success in Project Completion
5.2.5 Internal Drug Discovery Programmes
5.3 Service Offerings of Leading Companies in the Drug Discovery Outsourcing Market
5.4 Albany Molecular Research (AMRI)
5.4.1 Sales and Recent Financial Performance, 2011-2013
5.4.2 AMRI’s Drug Discovery Services
5.4.3 Internal Portfolio of Drug Discovery and Development Programme Collaborations
5.5 Aptuit
5.5.1 INDIGO: Accelerating Early Drug Candidates
5.5.2 Aptuit Clinical Trial Supplies
5.5.3 Strategic Partnerships, Acquisitions and Divestitures
5.5.3.1 Divestiture of Aseptic Clinical Manufacturing
5.5.3.2 Aptuit’s Extended Partnership with GSK for Verona Centre
5.5.3.3 Partnership with Siena Biotech
5.5.3.4 Partnership with Laurus Labs
5.6 Charles River Laboratories
5.6.1 Sales and Recent Financial Performance, 2011-2013
5.6.2 Charles River Laboratories: An External Acquisition Strategy
5.6.2.1 Acquisition of ChanTest
5.6.2.2 Acquisition of Galapagos’ CRO Services Division (BioFocus and Argenta)
5.6.2.3 Acquisition of VivoPath
5.6.3 Charles River Laboratories: Revenue and Financial Analysis, 2014
5.6.3.1 Charles River Laboratories: Financial Performance by Business Segment, 2013-2014
5.6.4 Charles River Laboratories Sales Forecast, 2015-2025
5.7 Covance (Acquired by LabCorp)
5.7.1 Covance: Historical Revenue and Financial Performance, 2010-2013
5.7.2 Covance: Early Stage Discovery Efforts
5.7.3 Agreement with Sanofi
5.7.4 Agreement with Kellogg Company
5.7.5 Agreement with BioPontis Alliance
5.7.6 Agreement with Indiana Clinical and Translational Sciences Institute (CTSI)
5.7.7 Agreement with Eli Lilly
5.8 Cyprotex
5.8.1 Historical Revenue and Financial Performance, 2011-2013
5.8.2 Cyprotex: Revenue by Region, 2013
5.8.3 Cyprotex: Revenue Analysis and Forecast 2015-2025
5.9 Domainex
5.9.1 Drug Pipeline
5.9.2 TBK1/ IKKε Inhibitors
5.9.3 Methyltransferase (KMTS) Inhibitors
5.10 Evotec
5.10.1 Strategic Action Plan
5.10.2 Evotec: Revenue and Financial Analysis, 2010-2013
5.10.3 EVT Integrate and EVT Innovate
5.10.4 Partnerships with Pharma for Drug Discovery
5.10.4.1 Partnership with Sanofi
5.10.4.2 Extended Partnership with Evotec
5.10.4.3 Partnership with Johnson & Johnson
5.10.4.4 Partnership with AstraZeneca
5.10.4.5 Partnership with Bayer Pharma
5.10.4.6 Partnership with Boehringer Ingelheim Pharma
5.10.4.7 Collaboration with CHDI
5.10.4.8 Collaboration with Janssen
5.10.4.9 Collaboration with MedImmune
5.10.4.10 Collaboration with UCB Pharma
5.10.5 Evotec Sales Forecast, 2015-2025
5.11 GenScript
5.11.1 GenScript: Agreements and Partnerships
5.12 Pharmaceutical Product Development (PPD)
5.12.1 PPD: Agreements, Strategic Partnerships and Private Merger
5.12.1.1 Acquisition of Acurian
5.12.1.2 Partnership with Elan
5.12.1.3 Partnership with GSK
5.13 Quintiles
5.13.1Quintiles: Historical Revenue and Financial Performance, 2009-2013
5.13.2 Development Deal With Merck
5.13.3 Quintiles: Acquisition of Advion Bioanalytical Labs
5.13.4 Quintiles: Shedding Jobs
5.13.5 Quintiles Sales Forecast, 2015-2025
5.14 Selcia
5.14.1 A Strong Natural Product Chemistry Track Record
5.14.2 Initiative with the University of Edinburgh
5.14.3 Collaboration with Cantab
5.15 Viva Biotech
5.15.1 GPCR Targeted Discovery Programs
5.15.2 Antibody Therapeutics Discovery
5.16 WIL Research Laboratories
5.16.1 Focus on Preclinical Research
5.16.2 Acquisition of Ricerca Biosciences LLC
5.16.3 Acquisition of Midwest BioResearch
5.17 WuXi Apptec
5.17.1WuXi AppTec: Service Offerings
5.17.2 Acquisition of NextCODE Health
5.17.3 WuXi AppTec: Historical Revenue and Financial Performance, 2009-2013
5.17.4 WuXi AppTec: Laboratory Services Sales Forecast, 2015-2025
6. Qualitative Analysis of the Drug Discovery Outsourcing Market, 2015-2025
6.1 Drivers and Restraints in the Drug Discovery Outsourcing Market, 2015-2025
6.2 SWOT Analysis of the Drug Discovery Outsourcing Market, 2015-2025
6.3 Strengths
6.3.1 Cost Reduction: A Central Driver for Outsourcing
6.3.2 Accelerating the Discovery of Drug Candidates
6.3.3 Growth of Virtual Pharma Companies
6.3.4 Reduction in R&D capacity Within Big Pharma
6.4 Weaknesses
6.4.1 Slowing Trajectory of Growth for R&D Spending
6.4.2 Increasingly Saturated Market Requires Companies to Quickly Evolve
6.5 Opportunities
6.5.1 The Available Scope for the Expansion of CROs
6.5.2 Targeted Therapies: Advances in Biologics and Orphan Drugs
6.5.3 Increasing Development of Biologics and Biosimilars
6.6 Threats
6.6.1 A Competitive Market is Increasing Consolidation
6.6.2 Threat of Private Public Alliances
6.6.3 Intellectual Property Leaks
6.6.4 Challenges of Technology Transfer
6.7 Porter’s Five Force Analysis of the Drug Discovery Outsourcing Market
6.7.1 Threat of New Entrants: Medium
6.7.2 Power of Suppliers: Medium
6.7.3 Threat of Substitutes: Medium
6.7.4 Power of Buyers: High
6.7.5 Rivalry Among Competitors: High
7. Expert Opinions
7.1 Interview with Dr Mario Polywka, Chief Operating Officer, Evotec
7.1.1 Bridging the Gap Between Academia and Big Pharma
7.1.2 Evotec: Specialises in Certain Disease Therapies
7.1.3 Complete Drug Discovery Outsourcing: A Growing Trend
7.1.4 Strategies for Drug Discovery Outsourcing Expansion
7.1.5 Building Trust in Collaborations
7.1.6 Evotec: Proven Track Record of Success
7.2 Dr John Davis, Director of Discovery and Dave Roberts, Business Development Director, Radiochemistry, Selcia
7.2.1 Growth in the Full Spectrum of Outsourcing Services
7.2.2 Natural Products: Increasing Source of Drug Discovery
7.2.3 Strong Pool of Early Drug Candidates
7.2.4 Overcoming Drug Discovery Challenges using Drug Discovery
7.2.5 Selcia: Regional Base of Clients
7.2.6 Drug Discovery and Emerging Technologies
7.2.7 MedChemPlus Projects
7.2.8 Varied Customer Base
7.2.9 CROs: Improving Drug Discovery Productivity Levels?
7.3 Interview with Dr. Paul Overton, Executive VP, Business Development & Marketing, Aptuit
7.3.1 End-to-End Drug Discovery Integration Growth
7.3.2 Whole Project Externalisation
7.3.3 Drug Discovery Outsourcing: One of Aptuit’s Fastest Growing Services
7.3.4 Aptuit INDiGO® Program
7.3.5 Aptuit Implementation Drug Discovery Acquisitions
7.3.6 Aptuit: Adding the Intellectual Capabilities for Drug Discovery
7.3.7 Several Partners in the Drug Discovery Model
8. Conclusion
8.1 Market Overview
8.2 Lead Optimisation will be the Fastest Growing Sector
8.3 The Drug Discovery Outsourcing Market in Emerging Market Show Huge Gains
8.4 Continued Growth in Alliances and Collaborations
8.5 Concluding Remarks
【レポート販売概要】
■ タイトル：創薬アウトソーシングの世界市場■ 英文：Drug Discovery Outsourcing Market Forecast 2015-2025 : Opportunities for Leading Companies
■ 発行日：2015年3月
■ 調査会社：visiongain
■ 商品コード：VGAIN5040807
■ 調査対象地域：グローバル
- 商用製氷機の世界市場2016-2020：角氷製氷機、フレーク製氷機、ナゲットアイス製氷機About Commercial Ice Maker Machine An icemaker or an ice machine is a consumer device or a kind of refrigeration machinery for the production of ice. The size of an ice machine generally varies depending on the requirement. For instance, a small-scale ice maker is usually used as an individual appliance or fitted inside a freezer. However, large-scale production requires separate ice makers to be …
- 細胞単離/細胞分離の世界市場予測（～2024年）“The global cell isolation market is projected to register a CAGR of 17.2% during the forecast period.”The market size for cell isolation is expected to reach USD 13.0 billion by 2024 from USD 5.9 billion in 2019, at a CAGR of 17.2%. The growth in this market is attributed to the increasing number of patients suffering from cancer and infectious diseases, increasing government funding for cell-bas …
- 食品用酵素の世界市場：種類別（カルボヒドラーゼ、リパーゼ、プロテアーゼ、その他）、用途別（ベーカリー製品、飲料、乳製品、その他）、由来別（微生物、動物、植物）The food enzymes market size was valued at $1,944.8 million in 2018 and is expected to reach $3,056.9 million by 2025, registering a CAGR of 5.6% from 2019 to 2026. Food enzymes are complex ingredients, which act as catalyzers and are extensively used for increasing the diversity, variety, and quality during processing of food. Food enzymes are often used for food processing owing to its multiple …
- 群知能（SI）の世界市場予測（～2030年）The swarm intelligence market is expected to be valued at USD 447.2 Million by 2030, growing at a CAGR of 40.47% from 2020 to 2030, considering the technology will get commercialized by 2020. The major factors driving the growth of this market include the increasing usage of swarm intelligence for solving big data problems and the rising adoption of swarm-based drones in the military. In transport …
- 家庭用コーヒーグラインダーの世界市場2018-2022About Home Coffee Grinding Machines A home coffee grinding machine is used for grinding coffee beans at home. These coffee grinders are distinguished by consistency, the range of granularity, and low-temperature and low-noise operations. Technavio’s analysts forecast the global home coffee grinding machines market to grow at a CAGR of 5.77% during the period 2018-2022. Covered in this report The r …
- 透明導電体としての銀ナノマテリアル市場The growth of the touch-screen market has focused efforts on alternative materials that might make a dent in ITO’s dominance as a transparent conductor. Several years ago the hype was all about carbon nanotubes, but now it appears that nanomaterials made from silver are much more likely to gain market share. In this report, we assess the current state of the market for transparent conductors made …
- 電子タバコの世界市場2016-2020About the E-Cigarette Market An e-cigarette, also known as an e-vaping device, personal vaporizer, or electronic nicotine delivery system contains a heating element that vaporizes liquid nicotine or a flavored liquid. These liquids, called e-liquids, are available in more than 4,000 flavors, with vendors adding more than 300 flavors every month. One e-cigarette is equal to 6-8 tobacco cigarettes. …
- 世界のパワーディスクリート（Power Discrete）市場動向（2014-2018）TechNavio's analysts forecast the Global Power Discrete market to grow at a CAGR of 8.43 percent over the period 2013-2018. One of the key factors contributing to this market growth is the high demand for discrete IGBTs. The Global Power Discrete market has also been witnessing the emerging market for SiC and GaN power semiconductors. However, the low demand due to global economic slowdown could p …
- セミオートマチック・オートバイの世界市場2017-2021About Semi-automatic Motorcycles Currently, the market for semi-automatic motorcycles is at a nascent stage; therefore, the adoption of semi-automatic transmission systems in motorcycles market is slim. However, semi-automatic transmission is expected to gain traction in mass segment motorcycles, thereby fostering the market growth over the forecast period. Factors such as long distance traveling …
- 同期調相機の世界市場予測（～2021年）“The synchronous condensers market is expected to reach USD 572.9 million by 2021, at a CAGR of 2.1% from 2016 to 2021”The synchronous condensers market is projected to reach USD 572.9 million by 2021, growing at a CAGR of 2.1% from 2016 to 2021. The increasing electrical power consumption and rising need to maximize transmission capacity are becoming increasingly important. Along with this, growi …
- 世界の原子力発電展開動向（～2025）Fragile X Syndrome Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Fragile X Syndrome Global Clinical Trials Review, H2, 2013" provides data on the Fragile X Syndrome clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Fragile X Syndrome. It includes an overview of the trial numbers and their recruitme …
- スチレン系ブロック共重合体（SBC）及び誘導体の世界市場2016-2020：SBS、SIS、SEBS、HSBCStyrenic block copolymers, commonly known as SBCs, belong to the family of thermoplastic elastomers. These polymers are consumed in bulk compared with other thermoplastic elastomers and exhibit properties similar to rubber, though they are processed as thermoplastics. They are added in additives and other high-performance polymeric compounds for the formulation of many products. Technavio’s analys …
- フローティングLNG生産設備の世界市場2015-2019About Floating LNG Floating LNG refers to a system in which a set of operations and processes are performed for the development of offshore-based natural gas reserves. Floating LNG systems are mainly used for the production, liquefaction, storage, and transfer of LNG from offshore gas reserves to onshore areas. A floating LNG facility produces LNG directly on the offshore floating system, which un …
- 世界のデーターセンター建設市場動向（2012-2016）TechNavio's analysts forecast the Global Data Center Construction market to grow at a CAGR of 15.78 percent over the period 2012-2016. One of the key factors contributing to this market growth is the growing demand for colocation services. The Global Data Center Construction market has also been witnessing the use of alternative energy sources. However, the unstable economic conditions could pose …
- 予測分析アプリケーションの世界市場予測（～2020）The predictive analytics market size is expected to grow from USD 2.74 Billion in 2015 to USD 9.20 Billion by 2020, at an estimated Compound Annual Growth Rate (CAGR) of 27.4% during the forecast period. Increase in the amount of structured and unstructured data is the foremost factor that is driving the need of this market. Also, increased focus on market and competitive intelligence, transformat …
